2型糖尿病合并高血压患者的药学服务 |
作者:黄丽珍1 何娟1 彭桂芳1 张汉业2 |
单位:1. 紫金县人民医院药剂科, 广东 河源 517400; 2. 紫金县人民医院重症医学科, 广东 河源 517400 |
关键词:2型糖尿病 高血压 药学服务 |
中图分类号:R95 |
文献标志码: |
|
出版年,卷(期):页码:2017,27(1):42-44, |
收稿日期:2016-8-25 |
摘要:
|
目的 探讨药学服务在2型糖尿病合并高血压患者中的应用价值。方法 选取我院收治的2型糖尿病合并高血压患者资料64例,随机分为对照组和观察组。对照组31例按常规2型糖尿病合并高血压症治疗原则给予药物治疗;观察组33例由临床药师在常规治疗的基础上提供药学服务。观察比较随访前后2组体质量指数(BMI)、空腹血糖(FBG)、糖化血红蛋白(HbA1c)、收缩压(SBP)、舒张压(DBP)及用药依从性(Morisky评分)等指标的变化,记录不良反应发生率、用药差错率及满意率等情况。结果 治疗后,观察组的各项指标(BMI、FBG、HbA1c、SBP、DBP、Morisky)与治疗前比较,差异均有统计学意义(P<0.05,P<0.01);对照组的HbA1c、Morisky评分与治疗前比较,差异无统计学意义(P>0.05)。观察组的不良反应发生率和用药差错率低于对照组,而满意率高于对照组。结论 在2型糖尿病合并高血压症的治疗过程中,临床药师提供药学服务能够提高治疗效果,减少药物不良反应及用药差错的发生,并能提高患者的用药依从性和满意率。 |
OBJECTIVE To explore the value of pharmaceutical care on patients with type 2 diabetes mellitus(T2DM) and hypertension. METHODS 64 patients with T2DM and hypertension were randomly divided into control and observation group. 31 patients in control group received standard routine treatment, whereas 33 patients in observation group received pharmaceutical care besides standard routine treatment. The changes of body mass index(BMI), fasting blood glucose(FPG), glycosylated hemoglobin(HbA1c), systolic blood pressure(SBP), diastolic blood pressure(DBP) and medication adherence(Morisky) before and after treatment,adverse reactions(ADR), medication errors and satisfaction were observed and compared between the 2 groups. RESULTS After 3 months treatment, the indicators(BMI、FBG、HbA1c、SBP、DBP、Morisky) of observation group were significantly improved; while the levels of HbA1c and Morisky in control group had no significant difference before and after treatment. ADR and medication errors of observation group were lower than those in control group, observation group's satisfaction was higher than the control group. CONCLUSION Pharmaceutical care of clinical pharmacists could elevate the clinical therapeutic efficacy of T2DM and hypertension, reduce the ADR and medication errors, and improve the medication adherence and satisfaction. |
基金项目:
|
|
作者简介:
|
黄丽珍,副主任药师,Tel:07627826730,E-mail:279433464@qq.com |
通讯作者: |
参考文献:
|
[1] 唐能华,陈刘,邓武权,等.艾塞那肽治疗2型糖尿病合并高血压的临床研究[J].现代药物与临床,2016,31(3):310-314. [2] 郭永辉,张小民.阿托伐他汀联合普罗布考对糖尿病合并高血压患者血脂的影响[J].中西医结合心脑血管病杂志,2014,12(12):1508-1509. [3] 中华医学会糖尿病学分会.中国2型糖尿病防治指南[M]. 北京:北京大学医学出版社,2014:14-18. [4] 刘力生.中国高血压防治指南2010[J].中华高血压杂志,2011,39(8):701-708. [5] Gayar O,Timsina P,Nawar N,et al.A systematic review of IT for diabetes self-management:Are we there yet[J].Int J Med Inform,2013,82(8):637-652. [6] Cheung B M.The hypertension-diabetes continuum.[J].Journal of Cardiovascular Pharmacology,2010,55(4):333-339. [7] Holman R R,Paul S K,Bethel M A,et al.Long-term follow-up after tight control of blood pressure in type 2 diabetes.[J].New England Journal of Medicine,2008,359(15):1565-1576. [8] Kuritzky L.The role of combination therapy in type 2diabetes in the post-ACCORD era[J].Curr Diab Rep,2012,12(3):227-229. [9] 杨国柱,倪介平.糖尿病人治疗依从性258例分析[J].辽宁实用糖尿病杂志,2002,(4):26-27. [10] Oliveira-Filho A D D,Costa F A,Neves S J F,et al.Pseudoresistant hypertension due to poor medication adherence[J].International Journal of Cardiology,2014,172(2):309-310. [11] Persell S D,Bailey S C,Tang J,et al.Medication reconciliation and hypertension control.[J].American Journal of Medicine,2010,123(2):9-15. [12] Brinker S, Pandey A, Ayers C, et al. Therapeutic Drug Monitoring Facilitates Blood Pressure Control in Resistant Hypertension[J].Journal of the American College of Cardiology,2014, 63(8):834-835. [13] 张旭熙,孙凯歌,吴士艳,等.北京市通州社区2型糖尿病患者服药依从性和自我管理行为与其血糖控制的相关性研究[J].中国糖尿病杂志,2016, 24(9):773-777. [14] 卢丽姬,王虾仔,叶志龙.规范性随访干预对社区高血压患者服药行为改变的影响[J].今日药学,2016,26(4):274-276. [15] 韩群英,林亮君,丘敏,等.临床药师干预糖尿病老年患者用药依从性的效果分析[J].今日药学,2016,26(6):448-450. [16] 钱思兰,梅洵.糖尿病患者治疗依从性与病情控制和医疗费用调查分析[J].中国实用护理杂志,2013,29(5):60-62. [17] Bex S D,Boldt A S,Needham S B,et al.Effectiveness of a hypertension care management program provided by clinical pharmacists for veterans.[J].Pharmacotherapy,2011,31(1):31-38. [18] 梁小华.高血压糖尿病与老年人社区规范化管理成本测算研究[J].中国循环杂志,2013,28(1):14. [19] 李园,任多富,丁萍飞,等.中国8省(自治区)高血压和2型糖尿病患者健康管理服务实施现状[J].中华高血压杂志,2014,35(6):35-39. |
服务与反馈:
|
【文章下载】【发表评论】【查看评论】【加入收藏】
|
提示:您还未登录,请登录!点此登录 |
|